Persistent fatigue, brain fog, disrupted sleep, shortness of breath, and an unusually sensitive nervous system can continue long after an acute infection has passed. When symptoms remain unexplained, it is reasonable to look beyond the original virus and consider the inflammatory environment affecting the whole body.
The long covid cirs connection describes the overlap between post-viral symptoms and the immune, inflammatory, and cellular patterns associated with Chronic Inflammatory Response Syndrome. A functional medicine evaluation can help identify relevant exposures, immune dysregulation, and other root-cause factors while guiding individualized support.
CIRS is a multisystem illness often associated with biotoxins from water-damaged buildings, while Long COVID may involve persistent immune dysregulation, mast cell activation, and mitochondrial stress. These are not interchangeable diagnoses, but their shared biology may offer useful clinical questions. For a foundation, review our guide to understanding CIRS and post-viral illness. The next step is to examine where these conditions may intersect at the biological level.
Long Covid Cirs Connection: What Is the Overlap Between Long COVID and CIRS Biology?
The long COVID and CIRS connection becomes clearer when symptoms are viewed through shared biological pathways rather than through the original trigger alone. Long COVID may begin after a viral infection, while CIRS is commonly associated with biotoxin exposure, such as mold in a water-damaged building. Yet both can involve persistent immune signaling, impaired cellular energy production, and multisystem symptoms that continue after the initial threat appears to have passed.
Molecular hypometabolism can affect cellular energy
One proposed overlap is molecular hypometabolism, or MHM. In this state, cells may shift into a conservation pattern that affects energy production and normal communication between body systems. For a patient, that biology may be experienced as profound fatigue, exertion intolerance, cognitive difficulty, or slower recovery. This is one reason a person can feel significantly unwell even when routine testing does not explain the full picture.
Innate immune activation may remain switched on
Both conditions can also involve ongoing activation of the innate immune system, the body’s early-response defense network. Genetic differences in HLA antigen presentation may contribute to susceptibility. One clinical source estimates that approximately 22% of the population has genetic factors that can impair antigen presentation and promote chronic innate immune activation. This figure should be understood as a susceptibility estimate, not a diagnosis. It does not mean that everyone with a relevant HLA pattern will develop CIRS or Long COVID.
Inflammatory signaling shows measurable similarities
A transcriptomic study led by Dr. Ritchie Shoemaker and colleagues reported shared gene-expression patterns in people with Long COVID and CIRS. Transcriptomics examines which genes are more or less active, so this type of research can help compare biological patterns beyond symptom lists. The findings support further investigation into why some post-viral patients develop a persistent inflammatory pattern that resembles CIRS biology. A separate study of 120 people with Long COVID also evaluated inflammation and oxidative-stress markers, including C-reactive protein, malondialdehyde, myeloperoxidase, and glutathione peroxidase.
Two markers discussed in this overlap are TGF-beta1 and vascular endothelial growth factor, or VEGF. TGF-beta1 is reported as elevated in both CIRS and Long COVID, while VEGF is often low in both conditions. These markers are not standalone proof of either illness. They are pieces of a broader clinical assessment that may include exposure history, symptom patterns, examination, and appropriately selected testing.
| Feature | CIRS | Long COVID |
|---|---|---|
| Primary trigger | Biotoxins (mold, dinoflagellates) | SARS-CoV-2 infection |
| Genetic susceptibility | HLA-DR (15-25% of population) | Not well defined; HLA may play a role |
| TGF-beta1 level | Typically elevated | Often elevated |
| VEGF level | Typically low | Often low |
| Innate immune activation | Chronic, unresolved | Chronic in subset of patients |
| Multi-system symptoms | Yes (neuro, respiratory, GI, musculoskeletal) | Yes (similar range of systems) |
For a deeper explanation of understanding CIRS and post-viral illness, see Vaughan Vitality’s CIRS guide. Patients exploring a root-cause approach to Long COVID can also learn how functional medicine evaluates persistent symptoms without reducing the conversation to a single lab result.
Why Does the SARS-CoV-2 Spike Protein Trigger a Biotoxin Response?
For some people, the immune response after SARS-CoV-2 infection does not resolve in the usual way. Instead, the spike protein and other remnants of the infection may continue to stimulate inflammatory signaling. In a person with a particular HLA-DR genetic pattern, this can resemble the response seen after exposure to mold or another biotoxin. It is one proposed explanation for the long COVID and CIRS connection, although persistent symptoms can have more than one contributing cause.
Why HLA-DR susceptibility matters
Human leukocyte antigen, or HLA, molecules help the immune system present foreign material so it can be properly identified and cleared. Research and clinical models discussed in the literature suggest that approximately 22% of people have genetic factors that can impair this antigen-presentation process. When that clearance signal is incomplete, the innate immune system may remain activated even after the initial infection has passed.
This does not mean that a person is destined to develop CIRS or Long COVID. It means genetic susceptibility may influence how the body handles an inflammatory trigger. The same exposure can be followed by a relatively short recovery in one person and a prolonged, multisystem response in another. A careful history, examination, and appropriate testing are needed to distinguish a possible pattern from a diagnosis.
How a biotoxin-like pattern differs from a routine viral response
With a typical viral response, immune activity rises to control the infection and gradually quiets as recovery progresses. In a biotoxin-like pattern, the concern is ongoing innate immune activation combined with compromised antigen presentation. That chronic signaling may affect several systems at once, including energy metabolism, sleep, cognition, mood, pain regulation, and the body’s ability to regulate inflammation.
A July 2021 paper by Shoemaker and colleagues reported that people with new or persistent symptoms after acute COVID-19 had symptom and gene-expression patterns profoundly similar to those described in CIRS. That observation supports further investigation, but it does not prove that every case of Long COVID is CIRS or that spike protein is the only driver. Other factors, including the severity of the infection, reactivation of latent viruses, autonomic changes, and environmental exposures, may also matter.
At Vaughan Vitality, this distinction supports a root-cause evaluation rather than assuming every prolonged post-viral symptom follows the same pathway. The goal is to identify the patient’s inflammatory pattern and contributing exposures, then develop an individualized plan to support immune regulation and recovery.
What Labs Show a CIRS Pattern in Long COVID Patients?
Lab testing cannot, by itself, prove that persistent symptoms are caused by CIRS rather than another post-viral process. The value is in looking for a coherent pattern across immune regulation, vascular signaling, inflammation, and oxidative stress. A clinician should interpret these results alongside exposure history, symptoms, examination findings, medications, and other appropriate testing.
-
Start with TGF-beta1 and VEGF
TGF-beta1 is often elevated in both CIRS and Long COVID, while VEGF is often low in both conditions. That overlap is important because it supports the biological connection, but it does not distinguish the two on its own. Results need to be interpreted in context rather than treated as a stand-alone diagnosis. A clinician may use the combination as an initial signal to investigate whether persistent inflammatory and vascular-regulation problems fit a CIRS pattern.
-
Add MMP-9 and MSH to the pattern review
MMP-9 and MSH can add context about inflammatory signaling and immune regulation when reviewed with TGF-beta1 and VEGF. The key question is not whether one marker is slightly outside a reference range. It is whether several findings point in the same direction and match the patient’s history. Such as ongoing multi-system symptoms after an infection or a possible exposure to a water-damaged environment. Reference ranges and clinical meaning can vary, so testing should be ordered and interpreted by a qualified practitioner.
-
Check conventional inflammation and oxidative-stress markers
CRP offers a familiar measure of systemic inflammation. It can be useful, but a normal result does not automatically exclude a more complex inflammatory pattern. In a study of 120 people with Long COVID, researchers measured CRP alongside malondialdehyde (MDA), protein carbonyls, myeloperoxidase (MPO), nitric oxide, zinc, and glutathione peroxidase. The study reported that 31.7% of participants had severe oxygen-saturation abnormalities. These findings help show why a broader evaluation may be more informative than relying on a single inflammation marker. Read the published study.
-
Compare the laboratory picture with the clinical story
A CIRS-oriented interpretation asks whether the lab pattern, symptom clusters, and environmental history reinforce one another. Shoemaker-led transcriptomic research also identified gene-expression abnormalities shared by Long COVID and CIRS, supporting further investigation when the clinical picture fits. This does not mean every case of Long COVID is CIRS-driven. It means that some patients may benefit from a more targeted root-cause evaluation, including review of mitochondrial health in post-viral recovery. Vaughan Vitality can discuss appropriate reference lab testing and help determine which findings deserve follow-up.
Can the Shoemaker Protocol Help Long COVID Recovery?
The Shoemaker Protocol was developed for Chronic Inflammatory Response Syndrome (CIRS), a multisystem illness associated with biotoxin exposure. Because some people with persistent post-viral symptoms show overlapping immune and gene-expression patterns, clinicians may consider whether a CIRS-informed framework adds useful context to Long COVID care. A July 2021 publication by Shoemaker and colleagues reported that persistent symptoms after acute SARS-CoV-2 infection were profoundly similar to CIRS patterns. Although that similarity does not mean every Long COVID case has CIRS.
1. Remove the ongoing trigger
The first question is whether an ongoing biotoxin exposure is continuing to stimulate the immune system. This may include water-damaged buildings, hidden mold, or other environmental sources. If an exposure is suspected, appropriate inspection and remediation are important. Removing a patient from the source, when needed, gives the body a better opportunity to respond to the rest of the plan. Environmental assessment should be individualized rather than based on symptoms alone.
2. Support toxin clearance
In the Shoemaker approach, binders such as cholestyramine may be considered to help reduce the body’s reabsorption of certain biotoxins through the gut. These medications require clinical oversight because they can affect the absorption of other medicines and may not be appropriate for everyone. A practitioner may also review bowel function, hydration, nutrition, and medication timing before recommending this step.
3. Address hormonal and immune regulation
CIRS care may include evaluating hormonal signaling and immune regulation, including markers such as VIP and MSH. VIP nasal spray has been used in some CIRS protocols. But it is not a universal Long COVID treatment and should only be considered after a clinician reviews the patient’s history and testing. The broader goal is to address immune dysregulation rather than simply suppress one symptom. Research discussed in connection with CIRS also suggests that transcriptomic abnormalities can respond to FDA-cleared medications, a finding that supports continued clinical investigation rather than self-treatment.
How the Vitality Roadmap fits
At Vaughan Vitality, the three-phase Vitality Roadmap follows a similar root-cause sequence. Review & Identify examines history, exposures, symptoms, and relevant testing. Remove & Repair addresses contributing triggers and supports recovery. Rebalance & Replenish focuses on rebuilding resilience.
This framework does not assume that Long COVID and CIRS are interchangeable. It provides a structured way to ask better questions and coordinate individualized care. Learn more about the CIRS treatment roadmap and discuss whether this approach fits your situation with a qualified practitioner.
When Should You Suspect CIRS Rather Than Generic Long COVID?
Not every prolonged post-viral illness is caused by the same mechanism. A CIRS evaluation may be worth considering when symptoms began or repeatedly worsen after exposure to a water-damaged building, visible mold, flooding, or a persistently damp workplace. The exposure history matters because CIRS is a multisystem illness associated with biotoxins, not simply a label for fatigue that lasts after an infection.
Look for a multisystem pattern
Symptoms that span several systems can raise the need for a broader assessment. For example, a person may experience cognitive slowing or headaches alongside shortness of breath, sinus or respiratory complaints, digestive changes, and muscle or joint pain. Symptoms that do not meaningfully improve with rest, or that return after time in a damp environment, are additional clues to discuss with a qualified clinician. These signs are not diagnostic by themselves, but they can help distinguish a possible environmental trigger from a straightforward recovery pattern.
Review the full clinical picture, including labs
When the history and symptom pattern fit, clinicians may review markers associated with immune regulation and vascular signaling. A CIRS-oriented workup may show low vascular endothelial growth factor (VEGF), elevated transforming growth factor-beta 1 (TGF-beta1), or low melanocyte-stimulating hormone (MSH). These results require context. No single laboratory value can confirm CIRS, and testing should be interpreted alongside exposure history, examination findings, symptom progression, and other possible causes.
Genetic susceptibility may also be relevant. Published clinical discussions estimate that approximately 15% to 25% of people carry HLA-related factors associated with vulnerability to biotoxin illness, although estimates vary. A prominent real-world example is former NHL captain Jonathan Toews, who publicly discussed being diagnosed with CIRS after experiencing debilitating fatigue and lethargy following COVID-19. His story does not establish a diagnosis for anyone else, but it illustrates why persistent symptoms deserve careful investigation rather than assumptions.
If this pattern feels familiar, explore Long COVID recovery strategies and consider a comprehensive assessment. Schedule a Free Health Assessment with Vaughan Vitality to discuss your exposure history, symptoms, and appropriate next steps.
Frequently Asked Questions
Can mold exposure make Long COVID symptoms worse?
It may add another inflammatory burden for some people. CIRS is a multisystem illness often associated with biotoxins from water-damaged buildings, while Long COVID can involve persistent immune dysregulation. Reviewing current or past indoor-air exposures can help clarify whether environmental factors deserve attention alongside post-viral care. Learn more about CIRS and environmental triggers.
How is CIRS different from Long COVID?
The initiating trigger is usually different. Long COVID follows SARS-CoV-2 infection, whereas CIRS is often linked to biotoxin exposure, such as mold in a water-damaged building. Both can produce complex, multisystem symptoms involving immune activation and inflammation, so a thorough history and individualized evaluation are important.
What symptoms can overlap between CIRS and Long COVID?
Overlap may include persistent fatigue, cognitive difficulties, headaches, exercise intolerance, and symptoms affecting multiple body systems. Long COVID research also describes changes involving energy metabolism, the nervous system, immune function, and the gut microbiome. These similarities do not prove that every case has CIRS or the same underlying cause. Review the published comparison of Long COVID and ME/CFS.
Can functional medicine test for the long covid cirs connection?
Functional medicine does not use one test to confirm a universal connection. Instead, the evaluation may combine your illness timeline, symptom pattern, exposure history, medical records, and clinically appropriate testing. The goal is to identify whether viral, environmental, metabolic, or immune factors may be contributing to your symptoms and to guide personalized support.
How does Vaughan Vitality approach persistent post-viral symptoms?
Vaughan Vitality uses a phased framework: Review and Identify, Remove and Repair, and Rebalance and Replenish. This may include reviewing inflammatory triggers, environmental health, immune regulation, energy metabolism, and other relevant systems. The plan is individualized and intended to support the body’s recovery rather than promise a guaranteed outcome.
Ready to Explore Your Next Step?
Persistent symptoms after COVID can have more than one contributing factor. A thoughtful health review may help clarify patterns, identify questions for further evaluation, and support a more individualized plan. If you are ready to discuss your concerns with the Vaughan Vitality team, schedule your Free Health Assessment. This conversation can help you understand which next steps may be appropriate for your health goals.